JPWO2019145356A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019145356A5
JPWO2019145356A5 JP2020560576A JP2020560576A JPWO2019145356A5 JP WO2019145356 A5 JPWO2019145356 A5 JP WO2019145356A5 JP 2020560576 A JP2020560576 A JP 2020560576A JP 2020560576 A JP2020560576 A JP 2020560576A JP WO2019145356 A5 JPWO2019145356 A5 JP WO2019145356A5
Authority
JP
Japan
Prior art keywords
achondroplasia
pharmaceutical composition
chondrosis
fgfr3
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020560576A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021511379A5 (https=
JP2021511379A (ja
JP7286675B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/051622 external-priority patent/WO2019145356A1/en
Publication of JP2021511379A publication Critical patent/JP2021511379A/ja
Publication of JP2021511379A5 publication Critical patent/JP2021511379A5/ja
Publication of JPWO2019145356A5 publication Critical patent/JPWO2019145356A5/ja
Application granted granted Critical
Publication of JP7286675B2 publication Critical patent/JP7286675B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020560576A 2018-01-24 2019-01-23 Ｆｇｆｒ３関連軟骨異形成症の処置のための方法及び医薬組成物 Active JP7286675B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305053 2018-01-24
EP18305053.3 2018-01-24
PCT/EP2019/051622 WO2019145356A1 (en) 2018-01-24 2019-01-23 Methods and pharmaceutical compositions for the treatment of fgfr3-related chondrodysplasias

Publications (4)

Publication Number Publication Date
JP2021511379A JP2021511379A (ja) 2021-05-06
JP2021511379A5 JP2021511379A5 (https=) 2022-01-17
JPWO2019145356A5 true JPWO2019145356A5 (https=) 2022-01-17
JP7286675B2 JP7286675B2 (ja) 2023-06-05

Family

ID=61163620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020560576A Active JP7286675B2 (ja) 2018-01-24 2019-01-23 Ｆｇｆｒ３関連軟骨異形成症の処置のための方法及び医薬組成物

Country Status (5)

Country Link
US (2) US11951090B2 (https=)
EP (1) EP3743062B1 (https=)
JP (1) JP7286675B2 (https=)
ES (1) ES2985639T3 (https=)
WO (1) WO2019145356A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250041262A1 (en) * 2021-12-16 2025-02-06 Institut National de la Santé et de la Recherche Médicale Compositions for the treatment of fgfr3-related cognitive deficits with a catechin
US20250041263A1 (en) * 2021-12-20 2025-02-06 Institut National de la Santé et de la Recherche Médicale Use of catechin for the treatment of fgfr-related bone repair and bone formation impairment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016046375A1 (en) 2014-09-25 2016-03-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Theobroma cacao extract for use in the treatment or prevention of receptor tyrosine kinases related disorders

Similar Documents

Publication Publication Date Title
SU1505442A3 (ru) Способ получени производных оксазолидинона в виде @ -изомеров или смеси @ - и @ -изомеров, или их аддитивных солей с кислотами
DK2855426T3 (en) RELATIONSHIPS INHIBITING THE ACTIVITY OF CATECHOL-O-METHYL TRANSFERASE
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
JP2022078315A5 (https=)
JP2022506148A5 (https=)
PE20140963A1 (es) Compuestos de isoindolina para el tratamiento de cancer
JP2005507938A (ja) 置換チオアセトアミド
JP7840880B2 (ja) オマダサイクリンの結晶形態、その合成方法及びその使用方法
JO2793B1 (en) New Crystaline form V of Agomelatine, A process for It's Preparation and Pharmaceutical Compositions Containig it.
US12076315B2 (en) Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
BR9701774A (pt) Vacinas contra infecções cusadas pelo vìrus da febre amarela, cdna infeccioso de febre amarela, método para produzir um vìrus recombinante de febre amarela a partir de cdna infeccioso de febre amarela e plasmìdeos para o cdna infeccioso de febre amarela
JP2021514365A5 (https=)
JP2022502053A5 (https=)
ES3061097T3 (en) Lacosamide pharmaceutical composition and pharmaceutical preparation thereof
JPWO2019145356A5 (https=)
BR112022007207A2 (pt) Composição farmacêutica que compreende selexipag
JP2021511379A5 (https=)
CN115605485A (zh) 大环化合物的固体形式及其制备和用途
RU2008134142A (ru) Фармацевтическая гепатопротекторная композиция и способ лечения
EP4121050A1 (en) Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
JP2021091670A5 (https=)
CZ20023701A3 (cs) Inhibitory transportu fosfátu
ES2554924T3 (es) Derivados de quinolina antibacterianos
CZ178697A3 (en) Derivatives of erythromycin a and pharmaceutical composition containing thereof
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина